Department of Medicine, University of Alberta, 2F1.24 Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112th Street, Edmonton, Alberta, Canada T6G 2B7.
J Clin Endocrinol Metab. 2012 Apr;97(4):1179-86. doi: 10.1210/jc.2011-3055. Epub 2012 Jan 18.
The aim of the study was to determine whether heart failure is associated with an increased risk of major osteoporotic fractures that is independent of bone mineral density (BMD).
We conducted a population-based cohort study in Manitoba, Canada, by linking a clinical registry of all adults 50 yr of age and older who underwent initial BMD testing from 1998-2009 with administrative databases. We collected osteoporosis risk factors, comorbidities, medications, and BMD results. Validated algorithms identified recent-onset heart failure before the BMD test and new fractures after. The main outcome was time to major osteoporotic fractures (i.e. clinical vertebrae, distal forearm, humerus, and hip), and multivariable proportional hazards models were used for analyses.
The cohort consisted of 45,509 adults; 1,841 (4%) had recent-onset heart failure. Subjects with heart failure were significantly (P < 0.001) older (74 vs. 66 yr) and had more previous fractures (21 vs. 13%) and lower total hip BMD [T-score, -1.3 (sd 1.3) vs. -0.9 (sd 1.2)] than those without. There were 2703 incident fractures over the 5-yr observation. Overall, 10% of heart failure subjects had incident major fractures compared with 5% of those without [unadjusted hazard ratio (HR), 2.45; 95% confidence interval (CI), 2.11-2.85]. Adjustment for osteoporosis risk factors, comorbidities, and medications attenuated but did not eliminate this association (HR, 1.33; 95% CI, 1.11-1.60), nor did further adjustment for total hip BMD (HR, 1.28; 95% CI, 1.06-1.53).
Heart failure is associated with a 30% increase in major fractures that is independent of traditional risk factors and BMD, and it also identifies a high-risk population that may benefit from increased screening and treatment for osteoporosis.
本研究旨在确定心力衰竭是否与骨折风险增加相关,而这种相关性独立于骨密度(BMD)。
我们在加拿大马尼托巴省进行了一项基于人群的队列研究,将所有 50 岁及以上接受初始 BMD 检测的成年人的临床登记与行政数据库相链接。我们收集了骨质疏松症的危险因素、合并症、药物治疗和 BMD 结果。经过验证的算法可以识别出 BMD 检测前近期发生的心力衰竭和检测后新发的骨折。主要结局是发生主要骨质疏松性骨折(即临床椎体、远端前臂、肱骨和髋部)的时间,并使用多变量比例风险模型进行分析。
该队列由 45509 名成年人组成,其中 1841 人(4%)近期发生心力衰竭。与无心力衰竭的人相比,心力衰竭患者年龄明显较大(74 岁 vs. 66 岁),既往骨折次数更多(21 次 vs. 13 次),全髋 BMD 更低[T 评分,-1.3(标准差 1.3)vs. -0.9(标准差 1.2)]。在 5 年的观察期间,共发生 2703 例新发骨折。总体而言,10%的心力衰竭患者发生了新发的主要骨折,而无心力衰竭的患者为 5%(未调整的风险比[HR],2.45;95%置信区间[CI],2.11-2.85)。调整骨质疏松症危险因素、合并症和药物治疗后,这种关联虽然减弱但并未消除(HR,1.33;95%CI,1.11-1.60),进一步调整全髋 BMD 也未改变(HR,1.28;95%CI,1.06-1.53)。
心力衰竭与骨折风险增加 30%相关,这种相关性独立于传统危险因素和 BMD,同时还确定了一个高风险人群,可能受益于增加骨质疏松症的筛查和治疗。